# AptarGroup, Inc

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/AptarGroup, Inc).

## Overview

AptarGroup designs and manufactures dosing, dispensing, sealing and protection technologies used in drug delivery and consumer packaging. The company sells into pharmaceutical, fragrance, skincare, cosmetics, food, beverage, personal care and home care markets, where customers need precise product delivery, contamination protection and differentiated packaging functionality. It operates through three reporting segments: Pharma, Beauty and Closures. Aptar is headquartered in Crystal Lake, Illinois and runs manufacturing and sales operations across North America, Europe, Asia and Latin America.

## Products & services

• Drug delivery and dispensing systems
• Proprietary dosing and protection technologies
• Sealing solutions and pharma packaging
• Beauty and personal care dispensing systems
• Dispensing closures and food service trays

- **Pharma dispensing and drug delivery** (39%) — Proprietary dispensing systems, drug delivery systems, injectables components, active material science solutions and related services for prescription drug and consumer health markets.
- **Beauty dispensing systems** (29%) — Dispensing systems and sealing solutions for fragrance, facial skincare, color cosmetics and related beauty applications.
- **Closures and sealing solutions** (32%) — Dispensing closures, sealing solutions and food service trays used across food, beverage, personal care, home care and beauty markets.

- Drug delivery and dispensing systems
- Proprietary dosing and protection technologies
- Sealing solutions and pharma packaging
- Beauty and personal care dispensing systems
- Dispensing closures and food service trays
- Active material science solutions
- Digital health-related services

## Customers

Aptar sells primarily to branded consumer goods companies, pharmaceutical manufacturers and healthcare customers that need reliable, high-precision packaging components. In Pharma, customers include prescription drug, consumer health care and injectables companies that value regulatory support, safety of supply and specialized delivery formats. In Beauty, the customer base includes fragrance, skincare and cosmetics brands that use Aptar's dispensing systems to improve user experience and product differentiation. In Closures, Aptar serves food, beverage, personal care and home care customers that need functional closures, sealing performance and packaging convenience. The company has about 5,000 customers, and no single customer or affiliated group accounted for more than 4% of 2025 net sales, which reduces concentration risk.

- **Pharmaceutical and consumer health** (primary) — Buys drug delivery systems, injectables components, sealing solutions and pharma packaging to improve dosing accuracy, compliance and product protection.
- **Beauty and fragrance brands** (primary) — Buys dispensing systems for fragrance, facial skincare and color cosmetics to support premium positioning and differentiated user experience.
- **Food and beverage manufacturers** (secondary) — Buys closures, sealing solutions and food service trays to protect products, improve convenience and support packaging performance.
- **Personal care and home care brands** (secondary) — Buys pumps, closures and sealing solutions for soaps, cleaners and related products where functionality and cost efficiency matter.
- **Healthcare and specialty applications** (secondary) — Buys specialized components for ophthalmic, injectables and active material science applications where regulatory and technical requirements are high.

- Pharmaceutical companies buying drug delivery and dosing systems
- Consumer health customers needing regulated dispensing components
- Fragrance and cosmetics brands seeking differentiated packaging
- Skincare and personal care companies using pumps, sprays and closures
- Food and beverage producers needing closures and sealing solutions
- Home care brands requiring functional, high-volume dispensing formats
- Customers value regulatory compliance, safety of supply and design support

## Geography

Aptar operates globally, with manufacturing facilities across North America, Europe, Asia and Latin America and employees in approximately 20 countries. The company is headquartered in the United States, but its customer base and production footprint are international, which helps it serve multinational brands with local supply and shorter lead times. Management notes that customers increasingly prefer local suppliers for reactivity, service and safety of supply, especially in beauty and personal care. The company also faces exposure to regional cost structures, trade restrictions and currency translation, while its broad footprint supports resilience and customer proximity.

- Headquartered in Crystal Lake, Illinois, United States
- Manufacturing facilities span North America, Europe, Asia and Latin America
- Approximately 20 countries of operation support local supply and service
- Global footprint helps meet multinational customer requirements
- Local production is important where customers value shorter lead times
- International exposure creates currency and trade-related operating risk

## Strategy

Aptar's strategy centers on innovation in proprietary dispensing, dosing and protection technologies that can be sold across multiple end markets. The company emphasizes engineering, materials science, regulatory expertise and manufacturing scale as differentiators against regional and global competitors. It is also investing in capacity, equipment and new product development to support growth, while preserving the ability to generate cash for dividends, acquisitions and share repurchases. Management highlights sustainability-related product redesign, lower-carbon logistics and local manufacturing as part of its competitive positioning with customers and regulators.

- **Innovation in dispensing and drug delivery technologies** (medium-term) — Proprietary technology is the main source of pricing power and customer retention in a highly competitive packaging market.
- **Global manufacturing and local supply capability** (medium-term) — Customers increasingly prefer suppliers that can provide short lead times, service and supply security in multiple regions.
- **Sustainability-driven product redesign** (medium-term) — Regulatory and customer pressure on recycled content, recyclability and carbon footprint can reshape demand and product specifications.
- **Disciplined capital allocation** (short-term) — Cash generation is used to fund growth investments while supporting dividends, acquisitions and buybacks.

- Use proprietary technology to differentiate products beyond basic packaging
- Serve multiple end markets to reduce dependence on any one category
- Invest in innovation, regulatory support and product quality
- Maintain global manufacturing capability to win multinational accounts
- Expand capacity and equipment where customer demand requires it
- Improve sustainability attributes such as recyclability and lower-carbon supply
- Preserve cash flow for dividends, acquisitions and share repurchases

## Risks

Aptar operates in highly competitive markets where price pressure is persistent and local or regional competitors can undercut global suppliers. The company is exposed to regulatory change because its products and many customer end products must comply with FDA and other agency requirements, and changes in packaging rules can force redesigns or delay revenue. It also faces litigation and IP risk, including patent infringement and antitrust claims referenced in recent filings, which can create legal expense, injunction risk and operational disruption. Raw material availability and cost, especially PCR resins, can affect production economics, while tariffs, trade restrictions and macroeconomic weakness can reduce customer demand and pressure cash flow. Because Aptar has significant international operations, it also carries foreign exchange, tax and geopolitical exposure across Europe, Asia and Latin America.

- **Price competition from regional and global packaging suppliers** [high] — Aptar sells standardized and engineered components in markets where customers can switch suppliers based on price, service and lead time.
- **Regulatory and product compliance changes** [high] — FDA and comparable agencies can delay approvals or require design changes, which can postpone revenue and increase development costs.
- **Litigation and intellectual property disputes** [high] — Recent patent infringement and antitrust actions could lead to damages, injunctions or business interruption.
- **Raw material cost and availability** [medium] — PCR resins and other inputs can become more expensive or scarce, affecting output and customer pricing.
- **Trade, tariff and macro demand weakness** [medium] — Tariffs, inflation and slower consumer or pharma demand can reduce volumes and constrain capital spending.

- Intense price competition across all product lines and regions
- Regulatory changes may require product reformulation or redesign
- Patent and antitrust litigation can create legal cost and injunction risk
- Raw material shortages or inflation can disrupt production and margins
- Tariffs and trade restrictions can weaken demand and raise costs
- Foreign currency movements affect reported results and cash flows
- Customer demand can shift toward lower-carbon or more circular packaging

## Accounting

Aptar's reported results are influenced by judgment-heavy estimates, especially goodwill impairment testing, income taxes and contingencies. Goodwill is significant and allocated across Pharma, Injectables, Active Material Science Solutions, Beauty and Closures, so changes in cash flow forecasts, discount rates or market conditions could trigger impairment charges that would reduce operating income. The company also has meaningful foreign tax considerations, including a change in indefinite reinvestment assertions for certain foreign earnings, which affects deferred tax liabilities and potential repatriation taxes. Because Aptar uses restructuring, acquisition-related items and other special items in non-GAAP measures, investors should separate recurring operating performance from one-time adjustments when comparing periods.

- **Goodwill impairment** — A write-down would reduce operating income and equity.
- **Income taxes and indefinite reinvestment** — Can affect tax expense, balance sheet liabilities and cash tax planning.
- **Litigation and contingencies** — Can affect operating expenses and contingent liability disclosures.
- **Non-GAAP adjustments** — Impacts comparability and valuation multiples.

- Goodwill impairment testing can create large non-cash charges if forecasts weaken
- Foreign earnings and indefinite reinvestment assertions affect deferred tax liabilities
- Contingencies and litigation reserves may change with patent and antitrust cases
- Restructuring and acquisition-related items affect comparability of adjusted results
- Non-GAAP adjustments can materially change reported profitability trends
- Quarterly results may vary with customer demand, mix and currency translation

---

*Last updated: 2026-09-24T11:36:15.567345+00:00*